Context
The Drugs Controller General of India (DCGI) has approved the country’s first intra-nasal Covid-19 vaccine Bharat Biotech’s iNCOVACC for restricted emergency use in those aged above 18 years.
About
Bharat Biotech’s iNCOVACC:
Mode of working of the nasal vaccine:
Significance of Mucosal Vaccines:
Verifying, please be patient.